Leukemia/Lymphoma News

Cancer gene therapy advances

Seattle Genetics Reports Data from Phase I Trial of ADCETRIS® (Brentuximab Vedotin) in Front-line Ma

Cancer treatment 'blows tumours away in weeks'

Seattle Genetics Announces Antibody-Drug Conjugate Collaboration With Millennium

Seattle Genetics Receives FDA Fast Track Designation For SGN-35 For The Treatment Of Hodgkin Lymphoma

The news headlines shown above for Lymphoma / Leukemia are provided courtesy of Medical News Today.